Serum IP-10 has also been found to be raised in patients with recent-onset T1D [48, 49] and Graves’ disease (hyperthyroidism) [46], and to correlate with increased disease activity in SLE [50] and AS [51]. This evidence concerns the gene CXCL10 and Graves disease.